Matrix metalloproteinases are a highly regulated family of enzymes, that together can degrade most components of the extracellular matrix. These proteins are active in normal and pathological processes involving tissue remodeling; however, their sites of synthesis and specific roles are poorly understood. Using in situ hybridization, we determined cellular distributions of matrix metalloproteinases and tissue inhibitor of metalloproteinase-1, an inhibitor of matrix metalloproteinases, in endometrium during the reproductive cycle. The mRNAs for all the metalloproteinases were detected in menstrual endometrium, but with different tissue distributions. The mRNA for matrilysin was localized to epithelium, while the others were detected in stromal cells. Only the transcripts for the 72-kD gelatinase and tissue inhibitor of metalloproteinases-1 were detected throughout the cycle. Transcripts for stromelysin-2 and the 92-kD gelatinase were only detected in late secretory and menstrual endometrium, while those for matrilysin, the 72-kD gelatinase, and stromelysin-3 were also consistently detected in proliferative endometrium. These data indicate that matrix metalloproteinases are expressed in cell-type, tissue, and reproductive cycle-specific patterns, consistent with regulation by steroid hormones, and with specific roles in the complex tissue growth and remodeling processes occurring in the endometrium during the reproductive cycle. Abstract Matrix metalloproteinases are a highly regulated family of enzymes, that together can degrade most components of the extracellular matrix. These proteins are active in normal and pathological processes involving tissue remodeling; however, their sites of synthesis and specific roles are poorly understood. Using in situ hybridization, we determined cellular distributions of matrix metalloproteinases and tissue inhibitor of metalloproteinase-1, an inhibitor of matrix metalloproteinases, in endometrium during the reproductive cycle. The mRNAs for all the metalloproteinases were detected in menstrual endometrium, but with different tissue distributions. The mRNA for matrilysin was localized to epithelium, while the others were detected in stromal cells. Only the transcripts for the 72-kD gelatinase and tissue inhibitor of metalloproteinases-1 were detected throughout the cycle. Transcripts for stromelysin-2 and the 92-kD gelatinase were only detected in late secretory and menstrual endometrium, while those for matrilysin, the 72-kD gelatinase, and stromelysin-3 were also consistently detected in proliferative endometrium. These data indicate that matrix metalloproteinases are expressed in cell-type, tissue, and reproductive cycle-specific patterns, consistent with regulation by steroid hormones, and with specific roles in the complex tissue growth and remodeling processes occurring in the endometrium during the reproductive cycle. (J. Clin. Invest. 1994.94:946-953.) Key words: in situ hybridization * reproductive cycle * matrilysin -stromelysin -RNA
Introduction
Remodeling of the extracellular matrix is an integral part of normal tissue growth and differentiation, as well as pathological processes involving abnormal growth and tissue destruction.
Various members of a large family of matrix metalloproteinases (MMPs)' have been shown to be active in these processes (for reviews see references [1] [2] [3] [4] . The MMPs are collagenases, gelatinases, and stromelysins, with distinct but partially overlapping substrate specificities. Together they are capable of degrading most, if not all, of the components of the extracellular matrix. Most have been shown to be transcriptionally regulated by various oncogenes, cytokines, tumor promotors, growth factors, and other biologically active agents. All are secreted as proenzymes and require activation for proteolytic activity. MMP activity can be inhibited by another family of proteins, the tissue inhibitors of metalloproteinases (TIMPs), consisting of the related proteins TIMP-1 (5), TIMP-2 (6), and ChIMP-3 (7) . TIMP-1 expression is highly regulated and has been associated with the same tissues and cells expressing MMPs (2, 8) . Thus, the regulation of MMP and TIMP activity in tissues is complex and occurs at many levels.
MMP activity, synthesis, or secretion by a variety of cell types has been extensively studied and implicated as important in numerous pathological processes involving tissue destruction, including wound healing (8) , arthritis (9) , and tumor invasion and metastasis (10) . These proteins' roles in normal tissue formation and remodeling has been less frequently studied. MMP activity or expression has been detected in ovulation ( 11) , embryo implantation ( 12), and mammary gland involution following lactation (13) , all highly orchestrated events which are tightly regulated by hormones. MMPs have also been implicated in endometrial remodeling (14) (15) (16) (17) . One of the stromelysins, matrilysin, was initially isolated from involuting rat uteri (17) . Conditioned media of endometrial explants has been shown to release matrix metalloproteinase activity in vitro, and the activity was shown to be inhibited by progesterone (Osteen, K., W. Rodgers, M. Gaire, J. Hargrove, F. Gorstein, and L. Matrisian, manuscript submitted for publication) (15, 16) .
Recently, using in situ and Northern hybridization and immunohistochemistry, we determined that matrilysin expression is restricted to the epithelium of the endometrium and that its expression varies during the menstrual cycle in a pattern consistent with regulation by progesterone (14) . Matrilysin mRNA, localized by in situ hybridization, was always associated with matrilysin antigen in epithelial cells; while matrilysin antigen was also detected in stromal tissue during the menstrual phase. These data were consistent with diffusion of matrilysin antigen throughout stroma during the menstrual phase and suggested that matrilysin was a likely effector of the tissue breakdown occurring during menstruation. These data also indicated that detection of MMP mRNA by in situ hybridization was a better indicator of cellular MMP expression than immunohistochemical localization of MMP antigen due to the likely diffusion of matrilysin antigen in tissues.
The understanding of the roles played by MMPs and TIMPs in normal and pathological processes has been hampered by a lack of information on the expression of individual members of the MMP and TIMP families in these tissues. To place our observations of endometrial matrilysin expression in perspective of the spectrum of expression of other members of the MMP and TIMP families, we extended our localization studies to examine, at the level of metalloproteinase RNA expression, the patterns of expression of most of the known MMPs and TIMP-1 to provide insight into the roles MMPs and TIMP may play in the dramatic tissue remodeling and degeneration occurring in the cycling endometrium and in normal tissues in general.
Methods
Tissues. This study was conducted in accordance with institutional committees for the protection of human subjects, using tissue in excess of that required for diagnostic purposes. The majority of the tissues used in this study were those of Rodgers et al. (14) . Endometrial samples were obtained at the time of endometrial biopsy or hysterectomy, from women, ages 20 to 40, without a history of endometrial dysfunction, as determined by review of medical records. Tissues for RNA isolation were immediately frozen in liquid nitrogen and stored at -80'C. Hysterectomy specimens were placed on ice until examined and fixed in 10% neutral buffered formalin. Endometrial biopsy specimens were immediately fixed in 10% neutral buffered formalin. Endometrium were examined histologically, dated from hematoxylin and eosin stained sections according to the criterion of Noyes et al. (18) and grouped according to the stage of an idealized 28-d reproductive cycle as: proliferative (days 7-15), secretory (days [16] [17] [18] [19] [20] [21] [22] [23] [24] , late secretory (days [25] [26] [27] , and menstrual (days 28-6). Sections were cut at 5 HIm and mounted on 3-aminopropyltriethoxysilane-coated slides (Sigma Chemical Co., St. Louis, MO) (19) .
Hybridization probes. Hybridization probes were prepared from cloned human MMP cDNAs. All cDNAs were cloned in pGEM vectors (Promega, Madison, WI) except the stromelysin-3, and gelatinase cDNAs which were in Bluescript vectors (Stratagene, La Jolla, CA). (24) . The cDNA for TIMP-1 is an 810 bp EcoRI fragment containing the entire coding region of TIMP-1 (25) cloned in pGEM-3Z (8) . For in situ hybridization, full-length RNA transcripts from the sense and antisense strands were synthesized from the linearized plasmids by in vitro transcription using 3H-UTP (New England Nuclear, Boston, MA) to specific activities of approximately 108 dpm/Ig. For Northern blot hybridizations, single stranded RNA probes were prepared using 32P-UTP (14) . The MMP probes used did not cross hybridize with other MMP cDNAs or RNAs by Northern, Southern, and in situ hybridization (20, 26) .
In situ hybridization. In situ hybridization was performed as described in Rodgers et al. (14) . 3 (score of 1) to greater than 10-fold (score of 3) more grains/ positive cell using the antisense probe than the sense probe. All tissues were assayed at least two times with each probe. Identification of hybridized cells was confirmed using 40x objective with transmitted illumination. All tissues studied exhibited positive patterns of hybridization with at least one and usually two or more of the probes.
Northern analysis. Northern blots used in Rodgers et al. (14) were stripped and reprobed for this study. Blots were stripped by adding 100IC 0.1 x SSC, 5% SDS to the blots and shaking for 30 min at 650C, repeating and rinsing with water. Hybridization was in 4x SSPE, 50% formamide buffer with 1% SDS, 0.5% nonfat dried milk, 0.5 mg/ml denatured carrier DNA, and 0.25 mg/ml yeast tRNA and 2 x 106 cpm of probe/ml. All hybridizations were at 60°C overnight, followed by two brief rinses in 2x SSC/0.1% SDS at room temperature, two 30-min washings in lx SSC/0.1% SDS at 670C, and two 30 min washings in 0.2x SSC/0. 1% SDS at 670C. RNA retention in all blots was checked by hybridization of stripped blots to a chicken /3-actin probe.
Results
In situ hybridization of sections of endometrial tissues permitted us to determine the cellular sites of synthesis of MMP and TIMP-1 RNAs while preserving the cellular relationships within the tissue. Endometrial tissues were either immediately fixed in formalin at the time of biopsy or rapidly fixed after dissection from hysterectomy specimens which were obtained on ice and rapidly processed. No differences in the results from these tissues were obtained. Table I summarizes the hybridization results. Differences in the numbers of specimens studied for different probes is due to exhaustion of tissue blocks of some specimens before all MMPs or TIMP-1 were assayed. Representative photomicrographs of the hybridization reactions are in Figs. 1 Table I . Weak hybridization was repeatedly obtained in 2 of 8 proliferative endometrial specimens with antisense probe to stromelysin-1 and in 2 of 6 late secretory specimens with antisense probe to TIMP-1. In these cases the antisense (mRNA) probe hybridizations contained less than 2x the background number of grains as Matrix Metalloproteinases in Cycling Endometrium Fig. 1 D) . In early menstrual samples subtle differences in intensity of hybridization of stromal cells throughout the same tissue sections probed for different MMPs were observed. Antisense probe for stromelysin-l was most abundantly reactive with stromal elements immediately adjacent to glandular epithelium (Fig. 2 C) , while probes for the 72-kD gelatinase (Fig. 2 A) , and stromelysin-2 ( Fig. 1, 0 and P), and stromelysin-3 ( Fig. 1 M) were distributed throughout the stromal tissue. No specific localization of MMP probes was observed relative to vascular tissues.
TIMP-l RNA was detected in both epithelium and stroma with different proportions of stroma and epithelium reacting, depending on the stage of the cycle. TIMP-1 RNA was abundant in small arteriolar and capillary vascular tissue in the secretory endometrium (Fig. 1 I) , and in both the epithelium (Fig. 2 P. top left) and periglandular stroma (Fig. 2 P. bottom right) of different areas of the same section of menstrual endometrium.
Temporal expression of MMP and TIMP-J RNAs. MMP RNAs were expressed in the endometrium in reproductive stage specific groups, summarized in Fig. 3 . Matrilysin and stromelysin-3 RNAs were detected in proliferative (Fig. 1, A, B , and D), late secretory (Fig. 1, L , M, and N) and menstrual (Fig. 2,§ weak positivity. Mat, matrilysin; Strom, Stromelysin; Int Col, interstitial H and J) specimens; they were not detected in early or mid secretory endometrium. The 72-kD gelatinase (Figs. 1, E and G, and 2, A, B, and I) and TIMP-l (Figs. 1, I , and 2, E and P) RNAs were detected throughout the cycle; indeed, they were the only RNAs detected in the early to mid secretory endometrium (Figs. 1, G-K) . Stromelysin-2 (Figs. 1, 0 and P, and 2 0) and, except for weak expression in a few samples of proliferative endometrium, stromelysin-l (Fig. 2 C) RNAs were detected only in late secretory and menstrual endometrium. The 92-kD gelatinase (Fig. 2, M and N) and interstitial collagenase (Fig. 2 , G and L) RNAs were focally detected predominantly in menstrual endometrial stroma.
In previous studies, matrilysin RNA was focally abundant in restricted isolated endometrial glands in some specimens of late secretory endometrium (see reference 14) . In this study, stromelysin-2, and stromelysin-3 are also focally distributed in the stroma of late secretory endometrium, but not in the exact region exhibiting matrilysin expression (data not shown). Stromelysin-l RNA was not detected in late secretory endometrium. The 72-kD gelatinase RNA was more widely distributed and more frequently detected in the stromal cells from the late secretory period than the RNAs for stromelysin-3 or stromelysin-2. The intensity of the hybridization of the 72-k]) gelatinase probe was greatest in menstrual tissues. Stromal cells expressing MMP RNAs were more widely distributed in these tissues than glands expressing matrilysin RNA (data not shown). The intensity of TIMP1 probe hybridization paralleled that of the 72-kD gelatinase probe.
In menstrual endometrium all MMPs were detected, but in different tissue distributions. Matrilysin was present throughout the epithelium in tissue from the functionalis of early menstrual endometrium (Fig. 1 L) . The surrounding stromal cells contained abundant stromelysin-3 ( Fig. 1 M) , stromelysin-2 (Fig.  1, 0 and P), 72-kD gelatinase (Fig. 2 A and B) , and somewhat less abundant stromelysin-l (Fig. 2C) RNAs. Interstitial collagenase (Fig. 2 G) in proliferative endometrium-i.e., matrilysin (Fig. 2 H) , 72-kD gelatinase (Fig. 2 I ) and stromelysin-3 ( Fig. 2 J) are found in the epithelium and stromal cells respectively from the basalis endometrium (bottom of the sections) to the luminal menstrual tissue. The stromal cells of the luminal surface of the menstrual basalis endometrium showed intense hybridization in a bandlike distribution for stromelysin-2 ( Fig. 2 0) , 92-kD gelatinase (Fig. 2, M and N) , stromelysin-I and interstitial collagenase (Fig. 2 L) RNAs. Stromelysins-2, the 92-kD gelatinase and interstitial collagenase expression was particularly interesting in that the mRNA for these metalloproteinases was identified in the stromal cells of virtually all specimens only during the menstrual phase of the reproductive cycle. In menstrual specimens, collagenase and 92-kD gelatinase expression was much more focal (Fig. 2 G) than the expression of the other MMPs, being localized only to select regions of the stroma and not observed throughout the entire biopsy samples. TIMP-1 RNA was detected in both stromal and epithelial cells in menstrual specimens in complicated patterns which varied greatly from region to region in the tissue. In some areas the epithelium had an intense hybridization signal while in other areas the stroma was most intense (Fig. 2 P) .
Northern hybridization analysis. To confirm that the in situ hybridization method is sufficiently sensitive to exclude expression of RNAs which were not detected in the proliferative and secretory tissues, Northern hybridization was performed on stripped blots of endometrial RNAs isolated from endometrial biopsies used in previous studies of matrilysin RNA expression (14) . Stromelysin-2 RNA (Fig. 4 A) was not detected in all three specimens of RNA from early proliferative endometrium and was detected in 2 of 3 specimens from mid-late secretory endometrium. Positive hybridization for stromelysin-3 RNA (Fig. 4 B) was obtained in all proliferative RNA samples and in the same mid-late secretory samples reacting with stromelysin-2 probe. Positive hybridization for the actin probe (Fig. 4 B) confirmed the presence of hybridizable RNA on the blots. 72-kD gelatinase RNA was detected in all specimens, and stromelysin-I RNA was not detected in any of the specimens from the same blot (data not shown). 1-3) early, mid and late proliferative endometrium, (lanes 4 and 5) early secretory endometrium, (lanes 6-8) mid and late secretory endometrium.
Discussion
Sensitivity and specificity of the in situ hybridization assay. The concordance of results from three independent assays of matrilysin expression (in situ hybridization, Northern blot analysis and immunolocalization) in Rodgers et al. (14) and the concordance between Northern and in situ hybridization results for stromelysins-2 and -3 and the 72-kD collagenase in this report indicate that the in situ hybridization method is as sensitive as Northern hybridization for assay of MMP RNAs, even for determination of the absence of RNA in endometrium. The in situ hybridization method is theoretically able to detect as few as 10 transcripts/cell (27) , which is considerably less sensitive than the Northern hybridization method. So far this sensitivity appears adequate for determination of MMP transcription in these tissues. Presumably, this is due to relatively large changes in cellular RNA concentrations which are likely associated with MMP expression in these tissues. When the RNAs are not detected in the secretory phase, the RNA is presumably rapidly degraded below the level of detection of either method. When MMPs are being produced, their RNAs are sufficiently abundant so that they can be detected by either hybridization method.
Analysis of patterns of hybridization with the different MMP probes confirms that they do not cross react with other MMP RNAs in the in situ hybridization assays; thus, the patterns of hybridization with the various probes reflect biologically plausible distributions of MMP mRNAs within the tissues. The localization of hybridization of matrilysin probes to epithelium in tissues where other MMPs are present in stroma and not detected in epithelium confirms lack of cross reaction of the matrilysin probe with other MMP RNAs and lack or reaction of other MMP probes with matrilysin RNA. Lack of hybridization of the stromelysin-2 probe to proliferative phase stroma, which contains stromelysins-l and -3, and 72-kD gelatinase RNAs, confirms lack of cross reactivity of this probe with these MMP RNAs. Lack of hybridization of stromelysin-l probe to proliferative endometrium reacting strongly with stromelysin-3 confirms lack of cross reactivity between these reagents. Because the 72-kD gelatinase is detected in stroma of all endome- The RNA for stromelysin-3 is abundant in normal proliferative and menstrual endometrium. This MMP was originally isolated as a novel transcript of the stroma adjacent to invasive mammary carcinomas (22, 33) . Its abundant expression in endometrium suggests a role in normal tissue growth, which should be taken into account in evaluating its role in neoplastic processes. Similarly, the patterns of MMP and TIMP-1 expression in endometrium provide clues for the regulation of MMP activity in endometrium and for the roles played by various MMPs. Further study of metalloproteinase gene expression in the cycling human endometrium may shed light on the molecular mechanisms of steroidal regulation of MMPs and an understanding of how MMP regulation in normal and abnormal endometrium effects tissue remodeling and growth.
